Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 9Lymphoma, Non-Hodgkin 4HIV Infections 4Acquired Immunodeficiency Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Multi-centric Castleman's Disease 2Sarcoma, Kaposi 1Precancerous Conditions 1Neoplasms 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1Leukemia-Lymphoma, Adult T-Cell 1Hodgkin Disease 1HTLV-I Infections 1Epstein-Barr Virus Infections 1Dendritic Cell Sarcoma, Interdigitating 1Castleman Disease 1Brain Neoplasms 1AIDS-Related Opportunistic Infections 1AIDS-Related Complex 1

Interventions

ofatumumab 1liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Surveys and Questionnaires 1Sirolimus 1Rituximab 1Ritonavir 1Quality of Life 1Prednisone 1Metformin 1Lenalidomide 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphadenopathy × Zidovudine × Lymphoid × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡